Psychiatrists await esketamine with anticipation — and hesitation - STAT

Psychiatrists await esketamine with anticipation — and hesitation - STAT

The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression

By MEGAN THIELKING

STAT, ADOBE

The FDA is expected to decide soon whether to approve esketamine, which would become the first major depression treatment to hit the market in decades.

READ MORE